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Abstract
Background: Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent and highly heritable
childhood disorder. The dopamine D4 receptor (DRD4) gene has shown a genetic association with
ADHD in Caucasian populations with meta-analysis indicating a small but significant effect across
datasets. It remains uncertain whether this association can be generalised to non-Caucasian ethnic
groups. Here we investigate two markers within the DRD4 gene in a Taiwanese population, the
exon 3 variable number tandem repeat (VNTR) and a 5' 120 base-pair duplication.
Methods: Within-family transmission disequilibrium tests of association of the 5' 120 base-pair
duplication, and exon 3 VNTR in a Taiwanese population.
Results: No evidence of association of ADHD with either polymorphism in this population was
observed.
Conclusion: The DRD4 gene markers investigated were not found to be associated with ADHD
in this Taiwanese sample. Further work in Taiwanese and other Asian populations will therefore
be required to establish whether the reports of association of DRD4 genetic variants in Caucasian
samples can be generalised to Asian populations.
Background
Attention Deficit Hyperactivity Disorder (ADHD) is one
of the most prevalent and heritable childhood behav-
ioural disorders. Progress in identifying some of the genes
involved in ADHD susceptibility has been relatively fruit-
ful over the past decade by screening genetic variants that
lie within or close to genes that regulate neurotransmitter
systems, particularly dopamine pathway genes [1]. One of
the more consistent findings is the association with the 7-
repeat allele of a 48-base pair variable number tandem
repeat (VNTR) in exon 3 of D4 receptor gene (DRD4)
although there are a number of negative reports and dis-
crepancies between case control and within family studies
[2-22]. Meta-analyses of published and unpublished data
indicate a small but significant association across datasets
with no evidence of heterogeneity [23,24].
Other genetic variants in the DRD4 5'-regulatory region
have also been reported to be associated with ADHD. Of
particular interest is a 120-bp duplication that has been
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associated with ADHD in two studies [25,26] although
negative studies have also been reported [27-29,20].
Recently our group investigated the functional signifi-
cance of this repeat marker using in vitro reporter gene
assays and found that the long allele conferred lower tran-
scriptional activity than the shorter alleles in four different
mammalian cell lines [30].
Both the 120 bp duplication [10,31] and the exon 3 VNTR
[32-35] have also been associated with novelty seeking in
a few studies. Although the association with novelty seek-
ing is not as consistent as the association with ADHD and
was not significant in a meta-analysis of available data
[36], these reports remain of potential interest due the
clinical association of ADHD with risk taking and stimu-
lus seeking behaviours [37].
Here we set out to replicate these findings using a Taiwan-
ese sample of 216 ADHD probands that had previously
shown association to the dopamine transporter gene [38]
(Brookes et al., in review). Grady and colleagues [19] sug-
gest from their detailed analysis of sequence data across
DRD4 that in Caucasian populations the 7-repeat allele is
a relatively recent mutation that represents an independ-
ent clad and has been subject to positive selection. Their
data suggests that in Asian populations the 2-repeat allele
is a derivative of the Caucasian 7-repeat allele and we
might therefore expect to see association between the 2-
repeat allele and ADHD in Taiwanese populations
[35,44]. This hypothesis was not supported by Qian et al,
[17,18] who did observed a case-control association with
long repeat alleles (4–6-repeat alleles; p < 0.05) in a Han
Chinese population. This association, however, was not
supported using within family tests of association and the
association was not specific to any single allele. More
recent data from Leung and colleagues does however sup-
port this hypothesis by observing a significant increase in
prevalence of the 2-repeat allele in a Han Chinese ADHD
sample in comparison to a control sample (p = 0.015)
[45].
Methods
216 ADHD probands between the ages of 5–15 years and
available parents were recruited into the study from the
Child Psychiatric Clinics in the Chang Gung Memorial
Hospital in Taipei area, Taiwan. A total of 192 (83.6%)
were males. IQ was 50–69 in 13%, 70–89 in 44%, 90–119
in 40% and >120 in 1%. The diagnosis of ADHD was
made according to DSM-IV criteria following completion
of a standard maternal interview (Kiddie-SADS) [39] and
completion of parent and teacher Conner's revised rating
scales [40]. In all 78% had the combined subtype and
22% the inattentive subtype of ADHD.
Genotyping was carried out using standard PCR methods
and analysed on 2% agarose. Detection rate of DRD4 gen-
otypes was 87.5% for the VNTR and 96% for the 5' 120 bp
duplication. Both markers were in Hardy-Weinberg Equi-
librium, and no Mendelian errors were observed. The
family genotypes were analysed by single marker trans-
mission disequilibrium test (TDT), and haplotype-based
haplotype relative risk test (HHRR) run in UNPHASED
http://portal.litbio.org/Registered/Menu. UNPHASED
was also used to calculate haplotype associations for
phase-certain haplotypes (TDTPHASE) and for uncertain
haplotypes (HHRR) in addition linkage disequilibrium
between the markers.
Results
The TDT data revealed that neither marker investigated is
associated with ADHD in this sample, either individually,
or when combined together into a haplotype (Tables 1
and 2). The Global D' value between the two markers is
low (0.2) suggesting that the two markers segregate inde-
Table 1: Allele Frequencies from HHRR analysis and Transmission ratio (T/NT) for TDT. Global and allele-specific tests of association 
were non-significant.
Case Frequency(%) Control (NT) Frequency(%) T/NT transmission
5' marker
120 bp 0.232 0.236 54 / 55
240 bp 0.768 0.764 179 / 178
Exon 3 VNTR
2 0.234 0.244 46 / 48
3 0.005 0.000 1 / 0
4 0.751 0.736 149 / 146
5 0.010 0.020 2 / 4BMC Medical Genetics 2005, 6:31 http://www.biomedcentral.com/1471-2350/6/31
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pendently from each other in this population. Refining
the sample by removing those with IQ less than 70, did
not improve the significance of the finding for either the
exon III VNTR (TDT p = 0.55; HHRR p = 0.55), the 5'120
bp repeat (TDT p = 0.71; HHRR p = 0.73) or the haplotype
of the two markers (TDT p = 0.45; HHRR p = 0.45). Sub-
type specific tests of association for the combined and
inattentive subtypes analysed separately were non-signifi-
cant (data not shown).
Discussion
In summary we did not find the DRD4 markers to be asso-
ciated with ADHD in a Taiwanese sample that has previ-
ously shown association with the dopamine transporter
gene. As reported in previous studies in Asian populations
the VNTR 7-repeat allele was absent and we also failed to
replicate the previous reported associations in a Chinese
population with 4-repeat and 6-repeat alleles [17,18] and
in a Taiwanese population with the 2-repeat allele [45].
There have been no previously reported studies of the
120-bp repeat polymorphism and ADHD in Asian popu-
lations. Differences in association may also be due to dif-
ferential diagnosis because of difference in cultures
between western and eastern civilisations [48]. However
the previously reported association with the dopamine
transporter gene suggests that the clinical phenotype in
this sample is comparable with samples ascertained in
Europe, the United States and South America.
There are several possible explanations for the observed
findings. First it is entirely possible that increased risk to
ADHD associated with either of the markers studied may
be absent in Asian populations. The association with the
7-repeat allele reported in Caucasian populations may be
dependent on the presence of the 7-repeat allele itself and
therefore absent from any population with low frequency
of this allele. Critical sequences that increase risk for
ADHD may therefore be absent in this population. The
association with the 120-bp duplication has yet to be
established and these data lend no further support to this
potential finding. Second, our sample lacked power to
detect very small main effects with less than 80% power at
alpha = 0.05 for odds ratios less than 1.5 for associations
with either the 2-repeat or 4-repeat alleles. Furthermore, it
is feasible that environmental risk factors might interact
with genetic risk factors reducing or abolishing main
effects from genotype alone (e.g. [41,42]). In this case we
would have little chance of detecting such associations
unless we also had measured environmental risks. Third,
previous studies using within family tests of association
have failed to find evidence for association of the VNTR
polymorphism with ADHD, whereas case-control designs
have been more positive (discussed in [1]). The work of
Holmes et al [8] using a collaborative dataset suggests that
although there was no preferential transmission of the 7-
repeat allele, there was a significant TDT association in the
sub-group that had co-morbid conduct disorder. This is
consistent with a report that parent-proband trios samples
have a less severe clinical phenotype with lower levels of
ADHD and co-morbid symptoms [43]. The association
may therefore be present in co-morbid groups or groups
which have certain aspects of the ADHD phenotype such
as novelty seeking, cognitive impulsiveness [22], or
persistence of symptoms [21] that have not been meas-
ured in this sample.
Fourth, it has been noted that for within family tests of
association, dropped genotypes or genotyping errors for
risk alleles with population frequency of less than 0.5 may
give rise to false negative findings [49]. Although we were
careful to rule out genotyping errors by identifying and re-
genotyping ambiguous genotype calls, we did have a high
level of dropping genotypes. Both proband and parental
genotypes were however in Hardy-Weinberg Equilibrium
suggesting that no major genotype biases were affecting
this sample. We have attempted to deal with some limita-
tions of within family tests of association by looking for
case-control differences for the frequencies of the 2-repeat
alleles. Using frequency in Han Chinese controls as 20%
from data published by Leung and colleagues [45] and
comparing this to the allele frequency of the 2-repeat of
our probands (23.8%), there is no significant difference.
Table 2: Haplotype analysis of the two markers did not find either global or haplotype-specific evidence for association.
Haplotype Case (T) Frequency Control (NT) Frequency OR
1–2 17 0.095 12 0.068 1
1–4 21 0.119 26 0.15 0.57
2–2 25 0.144 31 0.176 0.59
2 – 3 10 . 0 0 6 000 . 7 2
2–4 110 0.625 103 0.583 0.77
2–5 2 0.011 4 0.36 0.36BMC Medical Genetics 2005, 6:31 http://www.biomedcentral.com/1471-2350/6/31
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One final explanation may be due to hypothesized reci-
procity between ADHD associations with the dopamine
transporter and DRD4. As hypothesised by Swanson and
colleagues [46] the risk allele for ADHD in the dopamine
transporter may represent a hyper-efficient variant,
whereas the risk alleles for the dopamine D4 receptor may
represent a sub-sensitive variant, both leading to a hypo-
dopaminergic system. Although additive or epistatic inter-
actions between these two genes are likely, it might also be
that they act independently of each other, describing two
distinct causes of ADHD. It is therefore possible that sam-
ples that have been found to be associated with the DAT1
10-repeat risk allele, may not also be associated to the
dopamine receptor D4 risk allele, due to over-representa-
tion of one allele or the other in particular populations.
For example our UK sample that has also been found to
be associated with DAT1 risk variants [47] (Brookes et al,
in review), was not found to be associated with the VNTR
polymorphism in the dopamine receptor D4 [15]. We
investigated this possibility by re-analysing the DRD4
findings separately for individuals homozygous for the
dopamine transporter risk allele and those with less than
two risk alleles however there was no suggestion of asso-
ciation in these two sub-groups (data not shown).
Conclusions
These results taken together with other reports of Taiwan-
ese and Asian samples find no consistency in the associa-
tion between genetic variants of DRD4 and ADHD.
Further work in Taiwanese and other Asian populations
will therefore be required to establish whether the reports
of association of DRD4 genetic variants in Caucasian sam-
ples can be generalised to Asian populations.
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